Clinical trial · Observational
Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy
Prospective, Double Arm, Comparative Study for the Evaluation of Postoperative Pain, QOL, and Determination of Inflammatory Markers In Patients Undergoing Robotics Versus Open Laparotomy Approach for Staging of Endometrial Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is being done to evaluate the efficacy of robotic approach for staging of endometrial cancer as compared to an equivalent abdominal approach. The primary objective is to measure and compare postoperative pain at rest at several time points between two groups of patients undergoing either robotic or open laparotomy approach for staging of endometrial cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Robotic Surgery candidates
- description
- Group of patients receive Robotic approach for endometrial cancer staging
- label
- Open Laparotomy Surgical Candidates
- description
- Patients receiving open laparotomy for endometrial cancer surgical staging
Primary outcomes (1)
- measure
- The outcome measure is mean difference in post operative pain VAS scores reported by subjects at rest at the several time points between two groups of patients undergoing either robotic or open laparotomy approach for staging of endometrial cancer.
- timeFrame
- up to 24 hours
Secondary outcomes (1)
- measure
- Secondary outcomes will include the measurement of post operative pain after leg extension, post operative quality of life, post operative opioid requirements during first 24hours, survival status up to five years.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Female subjects between ages 18-86 years old * Subject provided written consent * Preoperative diagnosis of stage i or II endometrial cancer * Subject scheduled to undergo robotic hysterectomy or open abdominal hysterectomy at The Ohio State University * Subject should be expected to be able to use and tolerate opioids for pain management * Pre operative health is graded as ASA I-III * ECOG(Eastern Cooperative Oncology Group)Performance status 0-3 * Subject willing to comply with scheduled visits Exclusion Criteria: * Subject is prisoner, pregnant, or under age 18 or over age 85 * Hypersensitivity to opioids * subject is breastfeeding * Preoperative Health grade ASA IV-V * ECOG Performance Status 4-5 * History of receiving prior chemotherapy or radiation therapy * Subject schedule for additional procedures at the same time as the surgical staging * Subject with pain related illness that to the PI discretion would interfere with study assessments. * Known history of alcohol, analgesic, or narcotic abuse within 12 months. * Subjects taking NSAID(nonsteroidal anti inflammatory drug medications)within 7 days prior to baseline visit. * Require and/or receive chronic analgesic therapy for any pain related condition * Severe acute or chronic medical or psychiatric condition that would interfere with the study results.
References
Publications (0)
Data not yet available